WS
HSTO

Wedbush Securities’s Histogen Inc. Common Stock HSTO Stock Holding History

Wedbush Securities’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-215
Closed -$46K – 1044
2019
Q1 		$46K Buy
+215
New +$86.7K ﹤0.01% 896
2016
Q4 		– Sell
-143
Closed -$57K – 902
2016
Q3 		$57K Buy
143
+53
+59% +$21.6K 0.01% 787
2016
Q2 		$37K Buy
90
+23
+34% +$11.3K 0.01% 747
2016
Q1 		$29K Buy
+67
New +$25.9K 0.01% 717

Other funds holding HSTO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Wedbush Securities's HSTO Position: Q2 2019 in Review

Wedbush Securities sold out of Histogen Inc. Common Stock (HSTO) in Q2 2019, closing a stake of 215 shares — an estimated $46K sold.

Wedbush Securities first reported a position in HSTO in Q1 2016 and held it in 4 quarters. The position peaked at $57K in Q3 2016. 36 funds tracked by Wall St. Rank hold HSTO as of Q2 2019.

  • Wedbush Securities reported no remaining Histogen Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Wedbush Securities sold 215 Histogen Inc. Common Stock shares in Q2 2019, an estimated $46K.
  • Wedbush Securities first reported a position in Histogen Inc. Common Stock in Q1 2016 and held it in 4 quarters.
  • Wedbush Securities's Histogen Inc. Common Stock position peaked at $57K in Q3 2016.
  • 36 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2019.

Based on Wedbush Securities's 13F filing for Q2 2019, filed 1 Aug 2019.